November 7, 2023 02:32 PM ESTUpdated 02:43 PM

Activist investor Elliott buys $1B+ stake in BioMarin as CEO change nears

Andrew Dunn

Senior Biopharma Correspondent

The activist investing giant Elliott Investment Management has bought over a $1 billion stake in BioMarin, a person familiar with the matter tells Endpoints News …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Activist investor Elliott buys $1B+ stake in BioMarin as CEO change nears

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Investors pump $130M into protein degrader startup GlycoEra

Prothena’s amyloidosis drug flops again, spending and staff cuts are on the way

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Ac­tivist in­vestor El­liott buys $1B+ stake in Bio­Marin as CEO change nears

Senior Biopharma Correspondent

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Activist investor Elliott buys $1B+ stake in BioMarin as CEO change nears